Drug Shortage Report for BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Report ID | 164970 |
Drug Identification Number | 02509172 |
Brand name | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION |
Common or Proper name | Bendamustine Hydrochloride for Injection House Std. |
Company Name | JAMP PHARMA CORPORATION |
Market Status | DORMANT |
Active Ingredient(s) | BENDAMUSTINE HYDROCHLORIDE |
Strength(s) | 100MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1 vial x 100 mg |
ATC code | L01AA |
ATC description | ALKYLATINGAGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-07-19 |
Estimated end date | 2023-12-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-06-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2023-06-22 | French | Compare |
v8 | 2023-06-22 | English | Compare |
v7 | 2023-03-11 | French | Compare |
v6 | 2023-03-11 | English | Compare |
v5 | 2022-12-09 | French | Compare |
v4 | 2022-12-09 | English | Compare |
v3 | 2022-07-20 | English | Compare |
v2 | 2022-07-19 | French | Compare |
v1 | 2022-07-19 | English | Compare |
Showing 1 to 9 of 9